Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Vascular Inflammation early discoverieS through Transformative computational Approaches

Project description

Decoding vascular inflammation through integrative intelligence

Vascular inflammation is a major driver of cardiovascular disease, including atherosclerosis, which is often diagnosed and treated only at advanced stages. Earlier intervention requires a better understanding of how inflammation emerges from interactions between mechanical, biological and chemical processes across scales. The ERC-funded VISTA project will develop a computational framework that integrates physics-based models with AI-driven knowledge networks. Combining biomechanics, mechanobiology and systemic processes influencing vascular health, the project will create virtual patient models that capture the dynamic mechanisms underlying vascular inflammation from its earliest stages. Beyond improving diagnosis and personalised therapies, VISTA aims to advance an integrative intelligence framework for studying multifactorial systems, where the complexity arising from interacting data, scales and mechanisms is embraced and structured.

Objective

Vascular inflammation (VI) drives most cardiovascular diseases, the leading cause of global mortality and disability, with atherosclerosis as a key manifestation. Current clinical strategies focus on advanced stages of atherosclerosis, where interventions yield limited benefits. VISTA aims to transform this paradigm by pioneering computational tools for early diagnosis and treatment, bridging the gap between preclinical research and clinical translation. VISTA integrates computational mechanics, chemo-mechano-biology, and machine learning to tackle the challenges of multifactorial diseases. By introducing groundbreaking in silico tools, it seeks to reshape our understanding of VI, advancing preventive and personalized cardiovascular medicine.

Key challenges in VI include: (1) Current approaches struggle to synthetise the wealth of evidence on the interplay between biomechanics, biology, and systemic processes. (2) Translating causal insights into clinical applications requires linking evidence to precise mechanisms. (3) Clinical approaches and preclinical research remain rooted in traditional theories, lacking support from in silico tools that fail to incorporate real-world perspectives.

VISTA tackles these challenges through three objectives: (1) Developing a graph-informed modelling approach to create virtual patient models by synthesizing evidence-based networks of multiscale interactions. (2) Uncovering mechanistic pathways of VI by creating workflows that combine physics-based models, surrogate modelling, and generative AI. (3) Demonstrating the credibility of in silico methods in clinics and biomedical research.

This roadmap will deliver an innovative framework for the early discovery of multifactorial VI mechanisms, uniquely integrating tissue biomechanics, systemic physiopathology, and cell biology. It will advance patient-specific modelling and enable in silico clinical trials, opening pathways for early interventions and transformative therapies.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-COG

See all projects funded under this call

Host institution

UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA
Net EU contribution
€ 1 997 500,00
Address
VIA CRACOVIA 50
00133 Roma
Italy
Region
Centro (IT) Lazio Roma
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 997 500,00

Beneficiaries (1)